DBD Diebold Nixdorf Incorporated Common stock

NYSE · Technology · Ver en SEC EDGAR ↗

$83,16

Precio · Jul 2, 2026

Fundamentales a fecha de Abr 30, 2026

Rango 52S

$54–$89

83% of range

Calificación del Analista

Margen de Beneficio Neto

2.5%

DBD Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas

Precio

$83.16

Capitalización Bursátil

$2.40B

P/E (TTM)

26.7

BPA (TTM)

$2.54

Ingresos (TTM)

$3.81B

Rendimiento div.

0.32%

ROE

9.3%

Deuda/Capital

0.9

Rango 52S

$54 – $89

DBD Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista

Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA

Ingresos y Beneficio Neto $3.81B

2018-12-31 → 2025-12-31

BPA $2.54

2018-12-31 → 2025-12-31

Flujo de caja libre —

Márgenes 2.5%

2018-12-31 → 2025-12-31

Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?

Métrica

Tendencia a 5 años

DBD

Mediana de Pares

P/E (TTM)

26.7

22.9

P/S (TTM) (P/V (TTM))

0.6

2.1

P/B (P/C)

2.2

4.6

EV / EBITDA

8.0

—

Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC

Métrica

Tendencia a 5 años

DBD

Mediana de Pares

Gross Margin (Margen Bruto)

25.3%

34.0%

Operating Margin (Margen Operativo)

6.4%

—

Net Profit Margin (Margen de Beneficio Neto)

2.5%

11.1%

ROA

2.6%

6.5%

ROE

9.3%

14.7%

ROIC

9.6%

—

Salud financiera Deuda, liquidez, solvencia — solidez del balance general

Métrica

Tendencia a 5 años

DBD

Mediana de Pares

Debt / Equity (Deuda / Patrimonio)

0.9

105.2

Current Ratio (Ratio corriente)

1.3

Quick Ratio (Ratio Rápido)

0.7

—

Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años

Métrica

Tendencia a 5 años

DBD

Mediana de Pares

Revenue YoY (Ingresos interanuales)

1.5%

—

Revenue CAGR 3Y (Ingresos CAGR 3A)

3.2%

—

Revenue CAGR 5Y (Ingresos CAGR 5A)

-0.50%

—

Métricas por acción BPA, valor contable por acción, flujo de caja por acción, dividendo por acción

Métrica

Tendencia a 5 años

DBD

Mediana de Pares

EPS (Diluted) (BPA (Diluido))

$2.54

—

Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar

Métrica

Tendencia a 5 años

DBD

Mediana de Pares

Dividendos Rendimiento, ratio de pago, historial de dividendos, CAGR a 5 años

Rendimiento por Dividendo

0.32%

Ratio de Pago

—

CAGR de Dividendos a 5 años

—

DBD Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista

COMPRA 7 analistas

Compra fuerte 2 28,6%
Compra 4 57,1%
Mantener 1 14,3%
Venta 0 0,0%
Venta fuerte 0 0,0%

Precio objetivo a 12 meses

3 analistas · 2026-06-29

Mediana $100.00

Media $98.33

← Por Debajo de Todos los Objetivos $83.16

Mín $95.00

Máx $100.00

Objetivo mediano $100.00 +20,3%

Objetivo medio $98.33 +18,2%

Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados

Sorpresa Media

0.39%

Próximo informe

Ago 04, 2026

Período	EPS Actual	EPS est.	Sorpresa
31 de marzo de 2026	$0.67	$0.62	0.05%
31 de diciembre de 2025	$2.75	$1.64	1.1%
30 de septiembre de 2025	$1.38	$0.94	0.44%
30 de junio de 2025	$0.94	$0.59	0.35%
31 de marzo de 2025	$0.37	$0.36	0.01%

Comparación con pares Métricas clave frente a competidores del sector

Ticker	Capitalización Bursátil	P/E	Ingresos interanuales	Margen Neto	ROE	Margen Bruto
DBD	$2.40B	26.7	1.5%	2.5%	9.3%	25.3%
P	—	—	15.6%	5.1%	13.6%	70.4%
HPQ	$25.48B	10.4	3.2%	4.6%	-311.8%	20.6%
IONQ	$16.27B	-24.7	201.8%	-392.6%	-24.4%	—
SMCI	$29.12B	29.2	46.6%	4.8%	17.9%	11.1%
GPGI	—	-15.7	-85.8%	-227.3%	-198.9%	48.0%
INFQ	—	—	—	—	172.0%	—
QUBT	$2.30B	-93.3	82.8%	-2738.1%	-1.9%	9.8%
CRSR	$633M	-49.5	11.9%	-1.1%	-2.6%	28.9%
KODK	$824M	-4.8	2.5%	-12.0%	-22.4%	21.7%
AAPL	$3.77T	34.2	6.4%	26.9%	159.4%	46.9%

Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja

Estado de resultados 17

Datos anuales de Estado de resultados para DBD
Métrica	2025	2024	2023	2023	2022	2021	2020	2019	2018	2017	2016	2015
Revenue	$3.81B	$3.75B	·	·	$3.46B	$3.91B	$3.90B	$4.41B	$4.58B	$4.61B	$3.32B	$2.42B
Cost of Revenue	$2.84B	$2.83B	·	·	$2.70B	$2.86B	$2.87B	$3.34B	$3.68B	$3.61B	$2.60B	$1.77B
Gross Profit	$961M	$920M	·	·	$757M	$1.04B	$1.03B	$1.07B	$899M	$1000M	$712M	$652M
R&D Expense	$87M	$94M	·	·	$121M	$126M	$133M	$147M	$157M	$156M	$110M	$87M
SG&A Expense	$632M	$644M	·	·	$742M	$776M	$859M	$909M	$894M	$934M	$761M	$488M
Operating Expenses	$719M	$738M	·	·	$969M	$906M	$-1.01B	$-1.09B	$1.22B	$1.09B	$882M	$593M
Operating Income	$242M	$182M	·	·	$-212M	$137M	$24M	$-27M	$-326M	$-94M	$-170M	$59M
Interest Expense	·	·	·	·	$199M	$195M	$267M	$203M	$155M	$117M	$101M	$32M
Other Non-op	$4M	$2M	·	·	$2M	$3M	$7M	$-4M	$-4M	$2M	$3M	$4M
Pretax Income	$125M	$47M	·	·	$-439M	$-51M	$-270M	$-229M	$-478M	$-192M	$-249M	$46M
Income Tax	$24M	$64M	·	·	$149M	$28M	$-1M	$117M	$37M	$28M	$-69M	$-14M
Net Income	$95M	$-16M	·	·	$-581M	$-79M	$-269M	$-341M	$-531M	$-242M	$-42M	$74M
EPS (Basic)	$2.57	$-0.44	·	·	$-7.36	$-1.01	·	·	$-7.48	$-3.20	$-0.60	$1.13
EPS (Diluted)	$2.54	$-0.44	·	·	$-7.36	$-1.01	$-3.47	·	$-7.48	$-3.20	$-0.60	$1.12
Shares (Basic)	36,800,000	37,600,000	·	·	79,000,000	78,300,000	·	·	76,000,000	75,500,000	69,100,000	64,900,000
Shares (Diluted)	37,200,000	37,600,000	·	·	79,000,000	78,300,000	77,600,000	76,700,000	76,000,000	75,500,000	69,100,000	65,600,000
EBITDA	$370M	$222M	·	·	$-212M	$137M	$24M	$200M	$-104M	$169M	$-25M	$123M

Balance general 30

Datos anuales de Balance general para DBD
Métrica	2025	2024	2023	2023	2022	2021	2020	2019	2018	2017	2016	2015
Cash & Equivalents	$369M	$296M	$550M	$391M	$307M	·	·	$281M	$458M	$535M	$653M	$314M
Short-term Investments	$29M	$17M	$13M	$14M	$25M	$34M	$37M	$10M	$34M	$81M	$64M	$40M
Receivables	$609M	$588M	$722M	$624M	$612M	$595M	$647M	$619M	$737M	$828M	$836M	$414M
Inventory	$521M	$528M	$590M	$746M	$588M	$544M	$498M	$466M	$610M	$714M	$738M	$369M
Prepaid Expense	$51M	$46M	$44M	$46M	$50M	$48M	$59M	$51M	$57M	$66M	$61M	$24M
Other Current Assets	$189M	$177M	$193M	$248M	$168M	$203M	$227M	$231M	$225M	$248M	$183M	$148M
Current Assets	$1.79B	$1.67B	$2.15B	$2.14B	$1.77B	$1.89B	$1.86B	$1.89B	$2.20B	$2.48B	$2.62B	$1.64B
PP&E (Net)	·	$128M	$159M	$166M	$121M	$138M	$178M	$232M	$304M	$364M	$387M	$175M
PP&E (Gross)	$226M	$170M	$173M	$166M	$600M	$632M	$714M	$758M	$798M	$783M	$864M	$609M
Accum. Depreciation	$81M	$42M	$14M	$0	$479M	$494M	$536M	$527M	$494M	$419M	$477M	$434M
Goodwill	$642M	$586M	$612M	$621M	$702M	$744M	$800M	$764M	$798M	$1.05B	$998M	$162M
Intangibles	$792M	$779M	$891M	·	$258M	$348M	$449M	$502M	$625M	$774M	$773M	$68M
Other Non-current Assets	$242M	$195M	$169M	$266M	$97M	$132M	$122M	$91M	$86M	$96M	$63M	$8M
Total Assets	$3.85B	$3.54B	$4.16B	$4.18B	$3.06B	$3.51B	$3.66B	$3.79B	$4.28B	$5.22B	$5.27B	$2.24B
Accounts Payable	$431M	$460M	$529M	$461M	$612M	$706M	$500M	$472M	$510M	$562M	$560M	$282M
Short-term Debt	·	$200.0K	$300.0K	$5M	$24M	$47M	$11M	$32M	$50M	$67M	$107M	$32M
Current Liabilities	$1.37B	$1.27B	$1.42B	$1.41B	$1.60B	$1.75B	$1.65B	$1.60B	$1.57B	$1.80B	$1.82B	$956M
Capital Leases	$92M	$76M	$65M	·	$77M	$103M	$93M	$106M	$0	·	·	·
Deferred Tax	$201M	$177M	$205M	$238M	$97M	$106M	$103M	$134M	$154M	$287M	$301M	$2M
Other Non-current Liabilities	$118M	$110M	$27M	$124M	$32M	$36M	$60M	$89M	$87M	$111M	$88M	$29M
Total Liabilities	$2.75B	$2.61B	$3.08B	$3.13B	$4.44B	·	·	·	·	·	·	·
Long-term Debt	$938M	$927M	$1.25B	·	$2.56B	·	·	·	·	·	·	·
Total Debt	$938M	$400.0K	$300.0K	·	$24M	$47M	$11M	$32M	$50M	$67M	$107M	$32M
Common Stock	$400.0K	$400.0K	$400.0K	$400.0K	$120M	$118M	$117M	$115M	$114M	$113M	$112M	$100M
Retained Earnings	$92M	$-1M	$17M	$0	$-1.41B	$-822M	$-742M	$-472M	$-131M	$374M	$663M	$760M
Treasury Stock	$131M	$0	$0	$0	$586M	$582M	$577M	$572M	$570M	$567M	$562M	$560M
AOCI	$78M	$-118M	$8M	$0	$-360M	$-378M	$-413M	$-375M	$-304M	$-196M	$-341M	$-318M
Stockholders' Equity	$1.10B	$930M	$1.06B	$1.04B	$-1.38B	$-845M	$-827M	$-530M	$-150M	$446M	$589M	$412M
Liabilities + Equity	$3.85B	$3.54B	$4.16B	$4.18B	$3.06B	$3.51B	$3.66B	$3.79B	$4.28B	$5.22B	$5.27B	$2.24B
Shares Outstanding	35,384,690	37,576,678	37,566,678	·	79,103,450	78,352,333	77,678,984	76,813,013	76,174,025	75,558,544	75,144,784	65,001,602

Flujo de Efectivo 14

Datos anuales de Flujo de Efectivo para DBD
Métrica	2025	2024	2023	2023	2022	2021	2020	2019	2018	2017	2016	2015
D&A	$128M	$132M	·	·	$56M	$71M	·	$226M	$248M	$252M	$135M	$64M
Stock-based Comp	$12M	$10M	·	·	$13M	$14M	$15M	$24M	$37M	$34M	$22M	$12M
Deferred Tax	$-48M	$-8M	·	·	$93M	$-13M	$-20M	$78M	$-14M	$-40M	$-44M	$-49M
Amort. of Intangibles	·	·	·	·	·	·	·	$144M	$153M	$159M	·	·
Restructuring	$94M	$106M	·	·	$124M	$28M	$82M	$50M	$65M	$49M	$59M	$21M
Other Non-cash	$115M	$124M	·	·	·	·	·	$149M	$184M	$24M	$-52M	$-64M
Operating Cash Flow	$301M	$149M	·	·	$-388M	$123M	$18M	$136M	$-104M	$37M	$29M	$37M
Investing Cash Flow	$-98M	$-46M	·	·	$-24M	$-49M	$-83M	$-7M	$34M	$-121M	$-561M	$-65M
Stock Repurchased	$131M	$0	·	·	$8M	$8M	$7M	$2M	$3M	$5M	$2M	$3M
Net Stock Activity	$-131M	$-6M	·	·	$-8M	$-8M	$-7M	$-2M	$-3M	$-5M	$-2M	$-3M
Dividends Paid	·	·	·	·	·	·	$0	$0	$8M	$31M	$65M	$76M
Financing Cash Flow	$-144M	$-366M	·	·	$350M	$-4M	$17M	$-216M	$11M	$-64M	$881M	$42M
Net Change in Cash	$76M	$-281M	·	·	$-70M	$65M	$-51M	$-88M	$-78M	$-110M	$341M	$-10M
Taxes Paid	$57M	$56M	·	·	$33M	$42M	$44M	$42M	$65M	$78M	$84M	$65M

Rentabilidad 8

Datos anuales de Rentabilidad para DBD
Métrica	2025	2024	2023	2023	2022	2021	2020	2019	2018	2017	2016	2015
Gross Margin	25.3%	24.5%	·	·	21.9%	26.7%	26.5%	24.2%	19.5%	21.9%	21.8%	27.0%
Operating Margin	6.4%	4.9%	·	·	-6.1%	3.5%	0.62%	-0.60%	-7.9%	-1.8%	-4.8%	2.4%
Net Margin	2.5%	-0.44%	·	·	-16.8%	-2.0%	-6.9%	-7.7%	-12.4%	-5.1%	-1.0%	3.0%
Pretax Margin	3.3%	1.3%	·	·	-12.7%	-1.3%	-6.9%	-5.2%	-11.3%	-3.8%	-7.2%	1.9%
EBITDA Margin	9.7%	5.9%	·	·	-6.1%	3.5%	0.62%	4.5%	-2.3%	3.7%	-0.75%	5.1%
ROA	2.6%	-0.43%	·	·	-17.7%	-2.2%	-7.2%	-8.5%	-11.9%	-4.4%	-0.88%	3.2%
ROE	9.3%	-1.7%	·	·	52.2%	9.4%	39.6%	100.4%	-3345.3%	-44.9%	-5.0%	18.1%
ROIC	9.6%	-7.0%	·	·	20.9%	-26.6%	-2.9%	8.1%	284.2%	-18.2%	-16.4%	17.1%

Liquidez y Solvencia 5

Datos anuales de Liquidez y Solvencia para DBD
Métrica	2025	2024	2023	2023	2022	2021	2020	2019	2018	2017	2016	2015
Current Ratio	1.3	1.3	1.5	·	1.1	1.1	1.1	1.2	1.4	1.4	1.4	1.7
Quick Ratio	0.7	0.7	0.9	·	0.4	0.3	0.4	0.4	0.5	0.8	0.9	0.8
Debt / Equity	0.9	0.0	0.0	·	-0.0	-0.1	-0.0	-0.1	-0.3	0.1	0.2	0.1
LT Debt / Equity	0.9	·	·	·	·	·	·	·	·	·	·	·
Interest Coverage	·	·	·	·	-1.1	0.7	0.1	-0.1	-2.3	-0.7	-1.6	1.8

Eficiencia 3

Datos anuales de Eficiencia para DBD
Métrica	2025	2024	2023	2023	2022	2021	2020	2019	2018	2017	2016	2015
Asset Turnover	1.0	1.0	·	·	1.1	1.1	1.0	1.1	1.0	0.9	0.9	1.1
Inventory Turnover	5.4	5.1	·	·	4.8	5.5	5.9	6.2	5.6	4.9	4.7	4.8
Receivables Turnover	6.4	5.7	·	·	5.7	6.3	6.2	6.5	5.9	5.5	5.3	5.9

Por Acción 6

Datos anuales de Por Acción para DBD
Métrica	2025	2024	2023	2023	2022	2021	2020	2019	2018	2017	2016	2015
Book Value / Share	$31.08	$24.74	$28.32	·	$-17.46	$-10.79	$-10.65	$-6.90	$-2.45	$6.22	$7.87	$6.34
Revenue / Share	$102.30	$99.76	·	·	$43.81	$49.87	$50.29	$57.48	$60.24	$61.05	$47.99	$36.88
Cash Flow / Share	$8.08	$3.97	·	·	$-4.91	$1.57	$0.23	$1.77	$-1.37	$0.49	$0.41	$0.56
Cash / Share	$10.43	$7.88	$14.65	·	·	·	·	·	·	$7.08	$8.69	$4.82
Dividend Paid / Share	·	·	·	·	·	·	$0	$0	$0	$0	$1	$1
EPS (TTM)	$2.54	$-0.44	·	·	$-7.36	$-1.01	$-3.47	$-4.48	$-7.48	$-3.20	$-0.60	$1.12

Tasas de Crecimiento 3

Datos anuales de Tasas de Crecimiento para DBD
Métrica	2025	2024	2023	2023	2022	2021	2020	2019	2018	2017	2016	2015
Revenue YoY	1.5%	·	·	·	-11.4%	0.07%	·	·	·	·	·	·
Revenue CAGR 3Y	3.2%	-1.3%	·	·	·	·	·	·	·	·	·	·
Revenue CAGR 5Y	-0.50%	·	·	·	·	·	·	·	·	·	·	·

Valoración (TTM) 14

Datos anuales de Valoración (TTM) para DBD
Métrica	2025	2024	2023	2023	2022	2021	2020	2019	2018	2017	2016	2015
Revenue TTM	$3.81B	$3.75B	$3.44B	·	$3.46B	$3.91B	$3.90B	$4.41B	$4.58B	$4.61B	$3.32B	$2.42B
Net Income TTM	$95M	$-16M	$-1.04B	·	$-581M	$-79M	$-269M	$-341M	$-531M	$-242M	$-42M	$74M
Market Cap	$2.40B	$1.62B	$1.09B	·	·	·	·	·	·	·	·	·
Enterprise Value	$2.94B	$1.30B	$524M	·	·	·	·	·	·	·	·	·
P/E	26.7	-97.8	·	·	·	·	·	·	·	·	·	·
P/S	0.6	0.4	0.3	·	·	·	·	·	·	·	·	·
P/B	2.2	1.7	1.0	·	·	·	·	·	·	·	·	·
P / Cash Flow	8.0	10.8	·	·	·	·	·	·	·	·	·	·
EV / EBITDA	8.0	5.9	·	·	·	·	·	·	·	·	·	·
EV / Revenue	0.8	0.3	0.2	·	·	·	·	·	·	·	·	·
Dividend Yield	0.32%	0.48%	0.71%	·	·	·	·	·	·	·	·	·
Earnings Yield	3.7%	-1.0%	·	·	·	·	·	·	·	·	·	·
Payout Ratio	·	·	·	·	·	·	0.00%	0.00%	-1.4%	-13.1%	-195.8%	102.6%
Annual Payout	$8M	$8M	$8M	·	$8M	$8M	$0	$0	$8M	$31M	$65M	$76M

Estado de resultados 17

Datos trimestrales de Estado de resultados para DBD
Métrica	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022
Revenue	$892M	$1.10B	$945M	$915M	$841M	$989M	$927M	$940M	$895M	·	$922M	$858M	$969M	$810M	$852M	$830M
Cost of Revenue	$679M	$824M	$700M	$681M	$639M	$757M	$690M	$696M	$687M	·	$697M	$649M	$751M	$617M	$691M	$644M
Gross Profit	$213M	$280M	$245M	$234M	$202M	$232M	$237M	$243M	$209M	·	$225M	$209M	$217M	$194M	$161M	$185M
R&D Expense	$22M	$21M	$20M	$22M	$23M	$24M	$23M	$22M	$24M	·	$25M	$26M	$29M	$27M	$33M	$32M
SG&A Expense	$157M	$176M	$151M	$154M	$152M	$165M	$165M	$152M	$162M	·	$201M	$184M	$184M	$163M	$214M	$181M
Operating Expenses	$180M	$197M	$171M	$178M	$173M	$190M	$190M	$172M	$185M	·	$229M	$211M	$260M	$188M	$252M	$269M
Operating Income	$33M	$82M	$74M	$56M	$30M	$41M	$46M	$71M	$24M	·	$-4M	$-2M	$-42M	$6M	$-92M	$-83M
Interest Expense	·	·	·	·	·	·	·	·	$44M	·	$70M	$82M	·	$51M	$50M	$48M
Other Non-op	$2M	$900.0K	$-900.0K	$2M	$2M	$-4M	$2M	$3M	$1M	·	$4M	$3M	$5M	$-10M	$5M	$3M
Pretax Income	$12M	$63M	$52M	$17M	$-7M	$6M	$10M	$45M	$-14M	·	$-702M	$-90M	$-127M	$-46M	$-133M	$-132M
Income Tax	$6M	$12M	$10M	$5M	$-2M	$6M	$30M	$32M	$-3M	·	$-25M	$21M	$30M	$4M	$64M	$51M
Net Income	$5M	$50M	$41M	$12M	$-8M	$6M	$-22M	$15M	$-15M	·	$-677M	$-111M	$-149M	$-50M	$-199M	$-183M
EPS (Basic)	$0.14	$1.33	$1.13	$0.33	$-0.22	$0.15	$-0.60	$0.40	$-0.39	·	$-8.46	$-1.40	$-1.88	$-0.63	$-2.52	$-2.33
EPS (Diluted)	$0.14	$1.32	$1.11	$0.33	$-0.22	$0.15	$-0.60	$0.40	$-0.39	·	$-8.46	$-1.40	$-1.88	$-0.63	·	·
Shares (Basic)	35,100,000	-74,500,000	36,500,000	37,200,000	37,600,000	-75,200,000	37,600,000	37,600,000	37,600,000	·	80,000,000	79,300,000	-157,800,000	79,100,000	79,000,000	78,700,000
Shares (Diluted)	35,700,000	-74,900,000	37,000,000	37,500,000	37,600,000	-75,300,000	37,600,000	37,700,000	37,600,000	·	80,000,000	79,300,000	100,000	79,100,000	·	·
EBITDA	$64M	·	$74M	$56M	$42M	·	$46M	$71M	$33M	·	$-4M	$10M	·	$6M	$-92M	$-69M

Balance general 30

Datos trimestrales de Balance general para DBD
Métrica	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022
Cash & Equivalents	$359M	$369M	$246M	$279M	$306M	$296M	$251M	$277M	$282M	$376M	·	·	$307M	·	·	·
Short-term Investments	$0	$29M	$17M	$15M	$8M	$17M	$11M	$9M	$19M	$17M	$11M	$17M	·	$15M	$31M	$42M
Receivables	$597M	$609M	$580M	$599M	$603M	$588M	$665M	$650M	$661M	$704M	$656M	$627M	$612M	$538M	$563M	$550M
Inventory	$553M	$521M	$600M	$574M	$553M	$528M	$641M	$633M	$636M	$666M	$648M	$640M	·	$666M	$642M	$621M
Prepaid Expense	$31M	$51M	$40M	$39M	$43M	$46M	$40M	$34M	$46M	$47M	$47M	$53M	·	$47M	$48M	$50M
Other Current Assets	$245M	$189M	$216M	$208M	$195M	$177M	$207M	$220M	$223M	$207M	$224M	$220M	·	$225M	$252M	$234M
Current Assets	$1.80B	$1.79B	$1.72B	$1.74B	$1.73B	$1.67B	$1.90B	$1.91B	$1.97B	$2.08B	$2.14B	$1.81B	·	$1.68B	$1.85B	$1.78B
PP&E (Net)	·	·	·	·	$131M	·	$144M	$147M	$153M	$159M	$119M	$120M	·	$112M	$117M	$132M
PP&E (Gross)	$225M	·	$205M	$198M	·	·	·	·	·	$168M	·	·	·	·	·	·
Accum. Depreciation	$84M	$81M	$69M	$61M	$51M	$42M	$46M	$35M	$28M	$9M	$498M	$490M	·	$453M	$467M	$501M
Goodwill	$632M	$642M	$642M	$641M	$604M	$586M	$620M	$602M	$606M	$597M	$713M	$702M	$702M	$650M	$689M	$732M
Intangibles	$765M	$792M	$808M	$816M	$784M	$779M	$846M	$833M	$858M	$884M	$227M	$245M	·	$254M	$290M	$324M
Other Non-current Assets	$237M	$242M	$213M	$210M	$178M	$195M	$312M	$291M	$285M	$257M	$248M	$252M	·	$250M	$277M	$288M
Total Assets	$3.83B	$3.85B	$3.72B	$3.74B	$3.63B	$3.54B	$3.90B	$3.85B	$3.94B	$4.02B	$3.41B	$3.09B	·	$2.91B	$3.18B	$3.32B
Accounts Payable	$483M	$431M	$462M	$431M	$450M	$460M	$479M	$490M	$537M	$529M	$504M	$636M	·	$624M	$718M	$624M
Short-term Debt	·	·	·	·	·	·	$800.0K	$500.0K	$500.0K	$5M	$1.25B	$84M	·	$2.44B	$11M	$10M
Current Liabilities	$1.40B	$1.37B	$1.26B	$1.27B	$1.28B	$1.27B	$1.31B	$1.34B	$1.42B	$1.41B	$3.09B	$1.74B	·	$3.90B	$1.66B	$1.66B
Capital Leases	$99M	$92M	$85M	$83M	$79M	$76M	·	·	·	$66M	·	·	·	·	·	·
Deferred Tax	$197M	$201M	$161M	$185M	$180M	$177M	$210M	$208M	$195M	$166M	$67M	$101M	·	$115M	$136M	$106M
Other Non-current Liabilities	$147M	$118M	$125M	$117M	$35M	$110M	$96M	$84M	$86M	$97M	$96M	$107M	·	$120M	$133M	$136M
Total Liabilities	$2.80B	$2.75B	$2.61B	$2.63B	$2.63B	$2.61B	$2.83B	$2.84B	$2.92B	$3.03B	$3.30B	·	·	·	·	·
Long-term Debt	$939M	$938M	$934M	$931M	$929M	$927M	$1.07B	$1.07B	$1.07B	$1.26B	$2.17B	$2.6K	·	·	·	·
Total Debt	$939M	·	$934M	$931M	$929M	·	$800.0K	$500.0K	$500.0K	$5M	$1.25B	$84M	·	$2.44B	$11M	$10M
Common Stock	$400.0K	$400.0K	$400.0K	$400.0K	$400.0K	$400.0K	$400.0K	$400.0K	$400.0K	$400.0K	$121M	$121M	·	$120M	$120M	$120M
Retained Earnings	$97M	$92M	$44M	$3M	$-9M	$-1M	$-5M	$17M	$2M	$-26M	$-2.19B	$-1.52B	·	$-1.25B	$-1.20B	$-1.01B
Treasury Stock	$191M	$131M	$80M	$40M	$10M	$0	·	·	·	$0	$586M	$586M	·	$586M	$585M	$585M
AOCI	$53M	$78M	$85M	$79M	$-49M	$-118M	$25M	$-64M	$-30M	$-36M	$-328M	$-354M	·	$-437M	$-412M	$-365M
Stockholders' Equity	$1.02B	$1.10B	$1.11B	$1.10B	$984M	$930M	$1.07B	$997M	$1.01B	$977M	$-2.14B	$-1.49B	·	$-1.33B	$-1.26B	$-1.02B
Liabilities + Equity	$3.83B	$3.85B	$3.72B	$3.74B	$3.63B	$3.54B	$3.90B	$3.85B	$3.94B	$4.02B	$3.41B	$3.09B	·	$2.91B	$3.18B	$3.32B
Shares Outstanding	34,751,349	35,384,690	36,202,209	36,859,610	37,463,960	37,576,678	37,566,678	37,566,668	37,566,668	37,566,668	80,031,494	79,609,121	·	79,065,985	79,043,588	78,927,653

Flujo de Efectivo 12

Datos trimestrales de Flujo de Efectivo para DBD
Métrica	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022
D&A	$31M	$31M	$32M	$53M	$34M	$38M	$79M	$54M	$9M	·	$13M	$12M	$14M	$13M	$15M	$14M
Stock-based Comp	$3M	$3M	$3M	$3M	$3M	$2M	$3M	$3M	$2M	·	$800.0K	$1M	$4M	$3M	$5M	$2M
Amort. of Intangibles	·	·	·	·	·	·	·	·	$24M	·	·	$18M	·	·	·	·
Restructuring	$24M	$45M	$13M	$16M	$20M	$27M	$32M	$11M	$37M	·	$19M	$15M	$25M	$21M	$78M	$0
Other Non-cash	$-8M	·	·	·	$9M	·	·	·	$-20M	·	·	$2M	·	·	·	$-59M
Operating Cash Flow	$32M	$218M	$37M	$30M	$16M	$196M	$-16M	$-8M	$-24M	·	$-242M	$-96M	$95M	$-176M	$-80M	$-226M
Investing Cash Flow	$20M	$-39M	$-26M	$-33M	$0	$-17M	$-12M	$2M	$-18M	·	$-5M	$-2M	$-23M	$6M	$-1M	$-6M
Stock Repurchased	$60M	$51M	$40M	$30M	$10M	$0	$-3M	$-2M	$0	·	$1M	$2M	$1M	$900.0K	$700.0K	$5M
Net Stock Activity	$-60M	·	·	·	$-10M	·	·	·	$-2M	·	·	$-2M	·	·	·	$-5M
Financing Cash Flow	$-62M	$-56M	$-44M	$-31M	$-13M	$-192M	$-5M	$-12M	$-158M	·	$542M	$21M	$116M	$53M	$115M	$66M
Net Change in Cash	$-14M	$125M	$-33M	$-25M	$9M	$-23M	$-26M	$-28M	$-204M	·	$295M	$-75M	$192M	$-124M	$26M	$-165M
Taxes Paid	$6M	$21M	$8M	$21M	$7M	$16M	$8M	$21M	$11M	·	$14M	$12M	·	·	·	·

Rentabilidad 8

Datos trimestrales de Rentabilidad para DBD
Métrica	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022
Gross Margin	23.9%	·	25.9%	25.6%	24.1%	·	25.5%	25.9%	23.3%	·	24.4%	24.4%	·	23.9%	18.9%	22.3%
Operating Margin	3.7%	·	7.8%	6.1%	3.5%	·	5.0%	7.5%	2.7%	·	-0.42%	-0.24%	·	0.68%	-10.7%	-10.1%
Net Margin	0.56%	·	4.3%	1.3%	-0.99%	·	-2.4%	1.6%	-1.6%	·	-73.4%	-13.0%	·	-6.2%	-23.4%	-22.1%
Pretax Margin	1.4%	·	5.5%	1.9%	-0.88%	·	1.1%	4.8%	-1.6%	·	-76.1%	-10.5%	·	-5.7%	-15.6%	-15.9%
EBITDA Margin	7.2%	·	7.8%	6.1%	5.0%	·	5.0%	7.5%	3.7%	·	-0.42%	1.1%	·	0.68%	-10.7%	-8.3%
ROA	0.13%	·	1.1%	0.32%	-0.22%	·	-0.57%	0.41%	-0.42%	·	-20.6%	-3.5%	·	-1.5%	-5.9%	-5.4%
ROE	0.50%	·	3.8%	1.2%	-0.83%	·	-2.2%	-2.6%	6.2%	·	39.9%	8.9%	·	4.5%	18.9%	19.6%
ROIC	0.90%	·	2.9%	2.0%	1.1%	·	-9.1%	2.1%	1.8%	·	0.43%	0.18%	·	0.54%	10.9%	11.5%

Liquidez y Solvencia 5

Datos trimestrales de Liquidez y Solvencia para DBD
Métrica	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022
Current Ratio	1.3	·	1.4	1.4	1.3	·	1.4	1.4	1.4	1.5	0.7	1.0	·	0.4	1.1	1.1
Quick Ratio	0.7	·	0.7	0.7	0.7	·	0.7	0.7	0.7	0.8	0.2	0.4	·	0.1	0.4	0.4
Debt / Equity	0.9	·	0.8	0.8	0.9	·	0.0	0.0	0.0	0.0	-0.6	-0.1	·	-1.8	-0.0	-0.0
LT Debt / Equity	0.9	·	0.8	0.8	0.9	·	·	·	·	·	·	·	·	·	·	·
Interest Coverage	·	·	·	·	·	·	·	·	0.5	·	-0.1	-0.0	·	0.1	-1.8	-1.7

Eficiencia 3

Datos trimestrales de Eficiencia para DBD
Métrica	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022
Asset Turnover	0.2	·	0.2	0.2	0.2	·	0.2	0.3	0.3	·	0.3	0.3	·	0.2	0.3	0.2
Inventory Turnover	1.2	·	1.1	1.1	1.1	·	1.1	1.1	1.1	·	1.1	1.0	·	1.0	1.1	1.1
Receivables Turnover	1.5	·	1.5	1.5	1.3	·	1.4	1.4	1.4	·	1.5	1.5	·	1.3	1.4	1.4

Por Acción 5

Datos trimestrales de Por Acción para DBD
Métrica	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022
Book Value / Share	$29.43	·	$30.58	$29.77	$26.27	·	$28.38	$26.53	$26.97	$26.00	$-26.68	$-18.66	·	$-16.81	$-15.91	$-12.88
Revenue / Share	$24.98	·	$25.55	$24.41	$22.37	·	$24.66	$24.93	$23.81	·	·	·	·	·	·	·
Cash Flow / Share	$0.89	·	·	·	$0.42	·	·	·	$-0.62	·	·	·	·	·	·	·
Cash / Share	$10.32	·	$6.80	$7.57	$8.18	·	$6.68	$7.37	$7.50	$10.01	·	·	·	·	·	·
EPS (TTM)	$1.36	·	$0.62	$-0.09	$-0.81	·	·	·	·	·	·	·	·	·	$-4.48	$-4.48

Valoración (TTM) 13

Datos trimestrales de Valoración (TTM) para DBD
Métrica	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022
Revenue TTM	$3.59B	·	$3.63B	$3.62B	$3.60B	·	·	·	·	$3.44B	$3.44B	$3.35B	·	$3.45B	$3.58B	$3.68B
Net Income TTM	$50M	·	$23M	$-4M	$-30M	·	·	·	·	$-1.04B	$-1.04B	$-543M	·	$-434M	$-415M	$-224M
Market Cap	$2.62B	·	$2.06B	$2.04B	$1.64B	·	$1.68B	$1.45B	$1.29B	$712M	·	·	·	·	·	·
Enterprise Value	$3.20B	·	$2.74B	$2.68B	$2.25B	·	$1.42B	$1.16B	$993M	$324M	·	·	·	·	·	·
P/E	55.5	·	92.0	-615.6	-54.0	·	·	·	·	·	·	·	·	·	·	·
P/S	0.7	·	0.6	0.6	0.5	·	·	·	·	0.2	·	·	·	·	·	·
P/B	2.6	·	1.9	1.9	1.7	·	1.6	1.5	1.3	0.7	·	·	·	·	·	·
P / Cash Flow	82.7	·	·	·	104.3	·	·	·	-55.1	·	·	·	·	·	·	·
EV / EBITDA	50.0	·	37.1	47.7	53.6	·	30.5	16.4	30.2	·	·	·	·	·	·	·
EV / Revenue	0.9	·	0.8	0.7	0.6	·	·	·	·	0.1	·	·	·	·	·	·
Dividend Yield	0.29%	·	0.37%	0.38%	0.47%	·	0.46%	0.53%	0.60%	1.1%	·	·	·	·	·	·
Earnings Yield	1.8%	·	1.1%	-0.16%	-1.8%	·	·	·	·	·	·	·	·	·	·	·
Annual Payout	$8M	·	$8M	$8M	$8M	·	$8M	$8M	$8M	$8M	$8M	$8M	·	$8M	$8M	$8M

Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años

Estado de resultados

	2025-12-31	2024-12-31	2023-12-31	2023-08-12	2023-08-11
Ingresos	$3.81B	$3.75B	—	—	—
Margen Bruto %	25.3%	24.5%	—	—	—
Margen Operativo %	6.4%	4.9%	—	—	—
Beneficio neto	$95M	$-16M	—	—	—
EPS Diluido	$2.54	$-0.44	—	—	—

Balance general

	2025-12-31	2024-12-31	2023-12-31	2023-08-12	2023-08-11
Deuda / Patrimonio	0.9	0.0	0.0	—	—
Ratio corriente	1.3	1.3	1.5	—	—
Ratio Rápido	0.7	0.7	0.9	—	—

Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos

📊

Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.

Tu selección se guarda y te sigue en todos los tickers.

DBD Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas

DBD Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista

Promedios móviles y superposiciones

Volumen

Osciladores

Impulso y tendencia

Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA

Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?

Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC

Salud financiera Deuda, liquidez, solvencia — solidez del balance general

Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años

Métricas por acción BPA, valor contable por acción, flujo de caja por acción, dividendo por acción

Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar

Dividendos Rendimiento, ratio de pago, historial de dividendos, CAGR a 5 años

DBD Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista

Precio objetivo a 12 meses

Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados

Comparación con pares Métricas clave frente a competidores del sector

Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja

Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años

Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos